Cellulitis Completed Phase 3 Trials for Oritavancin (DB04911)

Also known as: Cellulitis, unspecified

IndicationStatusPhase
DBCOND0014773 (Cellulitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01252719Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure InfectionTreatment
NCT01252732Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure InfectionTreatment